The trial data showed that women achieved dramatically superior outcomes compared to men across all dose groups
That difference is clinically meaningful
Back Day, JW, Ottaway, N, Patterson, JT, et al (13 July 2009) 'A new glucagon and GLP-1 co-agonist eliminates obesity in rodents', Nature Chemical Biology
Lyophilized peptide powders are more stable at ambient temperatures than reconstituted solutions, but they still benefit from appropriate storage conditions prior to shipping
The results spoke for themselves
Managing Sleep Disruption in Early GLP-1 Treatment Some individuals experience initial insomnia or frequent nighttime waking during the first few weeks on compounded semaglutide or tirzepatide, particularly if dosing escalates quickly